The DOI matches its Crossref record.
Implementation of personalized medicine services in community pharmacies: Perceptions of independent community pharmacists
Open accessAbstract
Objectives To evaluate the perceptions of independent community pharmacists within a regional independent community pharmacy cooperative on implementing personalized medicine services at their pharmacies and to gauge the pharmacists' self-reported knowledge of pharmacogenomic principles. Design Descriptive, exploratory, nonexperimental study. Setting American Pharmacy Services Corporation (APSC), 2011-12. Participants Pharmacists (n = 101) affiliated with the independent pharmacies of APSC. Intervention Single-mode survey. Main outcome measures Independent community pharmacists' interest in implementing personalized medicine services, perceived readiness to provide such services, and perceived barriers to implementation. Results 101 completed surveys were returned for data analysis. The majority of pharmacists surveyed (75%) expressed interest in offering personalized medicine services. When asked to describe their knowledge of pharmacogenomics and readiness to implement such services, more than 50% said they were not knowledgeable on the subject and would not currently be comfortable making drug therapy recommendations to physicians or confident counseling patients based on results of genetic screenings without further training and education. Respondents identified cost of providing the service, reimbursement issues, current knowledge of pharmacogenomics, and time to devote to the program as the greatest barriers to implementing personalized medicine services. Conclusion The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible. Future initiatives should focus on the development of comprehensive education programs to further train pharmacists for provision of these services.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Professionals also describe a lack in their own knowledge or a limited understanding, as quantitative studies demonstrate [36, 37, 44, 81, 82, 92, 103, 104].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“These and other studies [37, 44–47, 58, 86, 105–108] reveal the need for further education of many health care providers, however, this requirement may vary between professionals in different fields [53, 81].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 18
- Zineh, 2011, Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration, Pharmacotherapy, 31, 729, 10.1592/phco.31.8.729 · DOI
- Stanek, 2012, Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey, Clin Pharmacol Ther, 91, 450, 10.1038/clpt.2011.306 · DOI
- Lunshof, 2012, Pharmacogenomic testing: knowing more, doing better, Clin Pharmacol Ther, 91, 387, 10.1038/clpt.2011.339 · DOI
- Haga, 2012, Survey of US public attitudes toward pharmacogenetic testing, Pharmacogenomics J, 12, 197, 10.1038/tpj.2011.1 · DOI
- Haddy, 2010, Consumers’ views of pharmacogenetics—a qualitative study, Res Social Adm Pharm, 6, 221, 10.1016/j.sapharm.2009.08.002 · DOI
- Haga, 2011, Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results, Genet Med, 13, 887, 10.1097/GIM.0b013e31822077a5 · DOI
- Roederer, 2009, Pharmacists and pharmacogenetics, Am J Health Syst Pharm, 66, 1256, 10.2146/ajhp090152 · DOI
- Crews, 2011, Development and implementation of a pharmacist-managed clinical pharmacogenetics service, Am J Health Syst Pharm, 68, 143, 10.2146/ajhp100113 · DOI
- MacIntosh, 2009, Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists, J Am Pharm Assoc, 49, 26, 10.1331/JAPhA.2009.07122 · DOI
- Reiss, 2011, American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management, J Am Pharm Assoc, 51, e64, 10.1331/JAPhA.2011.11543 · DOI
- Padgett, 2011, Pharmacogenomics in a community pharmacy: ACT now, J Am Pharm Assoc, 51, 189, 10.1331/JAPhA.2011.10178 · DOI
- McCullough, 2011, Assessment of the pharmacogenomics educational needs of pharmacists, Am J Pharm Educ, 75, 51, 10.5688/ajpe75351 · DOI
- Roederer, 2012, Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing, Per Med, 9, 19, 10.2217/pme.11.87 · DOI
- Sansgiry, 2003, The human genome project: assessing confidence in knowledge and training requirements for community pharmacists, Am J Pharm Educ, 67, 1, 10.5688/aj670239 · DOI
- Sansgiry, 2004, Genetic testing: the community pharmacist's perspective, J Am Pharm Assoc, 44, 399, 10.1331/154434504323064048 · DOI
- Van Bebber, 2010, Capacity building for assessing new technologies: approaches to examining personalized medicine in practice, Per Med, 7, 427, 10.2217/pme.10.36 · DOI
- Wilke, 2011, The emerging role of electronic medical records in pharmacogenomics, Clin Pharmacol Ther, 89, 379, 10.1038/clpt.2010.260 · DOI
- Harris, 2009, Research Electronic Data Capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 · DOI · Paper page
Cited by
Sorted by citations
Erdmann, A., Rehmann-Sutter, C., & Bozzaro, C. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00682-8 · Cited by 86
Metadata
- Authors
- Alexander, K. M., Divine, H. S., Hanna, C. R., Gokun, Y., & Freeman, P. R.
- Affiliations
- East Tennessee State University (US)
- University of Kentucky (US)
- University of Kentucky HealthCare (US)
- Corresponding author
- Alexander, Katelyn M.
- Venue
- Journal of the American Pharmacists Association
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 54
- Issue
- 5
- Pages
- 510-517
- ISSN
- 1544-3191 (ISSN-L)
- PMC
- PMC9226962
- OpenAlex
- W2086004478
- Cited by
- 59
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 9 · 2021: 13 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 3 · 2014: 1
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Pharmacists Association (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000117)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- personalized medicine, pharmacogenomics, community pharmacists, independent community pharmacies, pharmacist perceptions, implementation barriers, pharmacy education, drug therapy recommendations
- MeSH terms
- Adult, Attitude of Health Personnel, Community Pharmacy Services, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Pharmacists, Pharmacogenetics, United States, Health Care Surveys, Professional Role, Young Adult, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
